Transcripts Merus N.V.

Actions

Temps Différé Nasdaq Autres places de cotation 22:00:00 29/12/2025			Varia. 5j.	Varia. 1 janv.
90,00 ^USD	-7,14 %		-.--%	-

29/12	Genmab abandonne le développement d'une thérapie anticancéreuse expérimentale	RE
12/12	Genmab finalise son offre publique d'achat sur la biotech néerlandaise Merus	MT

10/03/25	Transcript : Merus N.V. Presents at Leerink?s Global Healthcare Conference 2025, Mar-10-2025 11:20 AM
04/03/25	Transcript : Merus N.V. Presents at TD Cowen 45th Annual Healthcare Conference, Mar-04-2025 09:10 AM
20/02/25	Transcript : Merus N.V. Presents at Citi's 2025 Virtual Oncology Leadership Summit, Feb-20-2025 09:00 AM
07/12/24	Transcript : Merus N.V. - Special Call
18/11/24	Transcript : Merus N.V. Presents at Stifel 2024 Healthcare Conference, Nov-18-2024 03:00 PM
12/11/24	Transcript : Merus N.V. Presents at Guggenheim Securities Inaugural Healthcare Innovation Conference, Nov-12-2024 09:30 AM
28/05/24	Transcript : Merus N.V. - Special Call
06/06/22	Transcript : Merus N.V. - Special Call
17/02/22	Transcript : Merus N.V. Presents at 11th SVB Leerink Annual Global Healthcare Conference 2022, Feb-17-2022 12:00 PM
16/02/22	Transcript : Merus N.V. Presents at Citi’s 2022 Virtual Immuno-Oncology Summit, Feb-16-2022 01:30 PM
07/06/21	Transcript : Merus N.V. - Special Call
06/09/18	Transcript : Merus N.V. Presents at Citi's 13th Annual Biotech Conference, Sep-06-2018 09:00 AM
08/06/17	Transcript : Merus B.V. Presents at Jefferies 2017 Global Healthcare Conference, Jun-08-2017 03:00 PM
06/03/17	Transcript : Merus B.V. Presents at Cowen and Company 37th Annual Health Care Conference, Mar-06-2017 04:00 PM